Sugi Predict

Sugi Predict / Compounds / SCHEMBL83677

SCHEMBL83677

SCHEMBL83677

O=C(O)c1ccc(CCBr)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.56
▸ TP53 P04637 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ RARB P10826 6/20 0.53
▸ TDP1 Q9NUW8 2/20 0.52
▸ KMT2A Q03164 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ RARA P10276 1/20 0.50
▸ MTOR P42345 1/20 0.50
▸ SRD5A2 P31213 2/20 0.48
▸ CA12 O43570 1/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA3 P07451 1/20 0.46
▸ TYR P14679 1/20 0.46
▸ DRD1 P21728 1/20 0.46
▸ CA4 P22748 1/20 0.46
▸ CA6 P23280 1/20 0.46
▸ CA5A P35218 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL27719615 0.98 ALDH1A1 (0.54) ALDH1A1TP53TSHRRARBTDP1
Furan SCHEMBL28841956 0.87 TDP1 (0.45) ALDH1A1TP53TSHRRARBTDP1
SCHEMBL1831978 0.87 RARB (0.59) ALDH1A1TP53TSHRRARBKMT2A
SCHEMBL11359808 0.87 RARB (0.62) ALDH1A1TP53TSHRRARBKMT2A
SCHEMBL6256666 0.86 TDP1 (0.48) ALDH1A1TSHRRARBTDP1SRD5A2
SCHEMBL70166 0.85 TSHR (0.67) ALDH1A1TP53TSHRRARBKMT2A
Terephthalic Acid SCHEMBL4612225 0.85 TSHR (0.67) ALDH1A1TP53TSHRRARBKMT2A
Hydrochloric Acid SCHEMBL6139910 0.85 RARB (0.58) ALDH1A1TP53TSHRRARBKMT2A
SCHEMBL11612824 0.84 TDP1 (0.48) ALDH1A1TDP1KMT2AMEN1KDM4E
SCHEMBL27961330 0.84 TDP1 (0.48) ALDH1A1TDP1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 564 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4638706-A2 NANOFIBROUS SCAFFOLD FOR CELL CULTURING Cellevate AB (SE) 2025-10-29 — — EP claimed
WO-2024133700-A2 NANOFIBROUS SCAFFOLD FOR CELL CULTURING CELLEVATE AB (SE) 2024-06-27 — — WO claimed
CN-116199681-A Hole transport material with anchoring and passivation effects, preparation method thereof, perovskite solar cell and preparation method thereof 广东工业大学 2023-06-02 — — CN claimed
CN-112795018-B Organosilicon benzimidazole corrosion inhibitor and preparation method thereof 山东硅科新材料有限公司 2022-04-01 — — CN claimed
CN-112876627-A Block organosilicon benzimidazole corrosion inhibitor and preparation method thereof 张玉花 2021-06-01 — — CN claimed
CN-112795018-A Organosilicon benzimidazole corrosion inhibitor and preparation method thereof 张玉花 2021-05-14 — — CN claimed
CN-112574956-A Hybridoma cell strain secreting propamocarb monoclonal antibody and application thereof 江南大学 2021-03-30 — — CN claimed
CN-112250641-A Hydrochlorothiazide hapten, artificial antigen, antibody and preparation method and application thereof 华南农业大学 2021-01-22 — — CN claimed
CN-105348206-A Paclobutrazol semiantigen, antigen, antibody and preparation method WANG QIUYAN 2016-02-24 — — CN claimed
US-12582641-B2 Sulfur-containing compound based on glutarimide skeleton and application thereof SHANGHAITECH UNIVERSITY (CN) 2026-03-24 — — US disclosed
EP-4638707-A1 NANOFIBROUS SCAFFOLD FOR INDUSTRIAL SCALE CELL CULTURING Cellevate AB (SE) 2025-10-29 — — EP disclosed
EP-4638706-A2 NANOFIBROUS SCAFFOLD FOR CELL CULTURING Cellevate AB (SE) 2025-10-29 — — EP disclosed
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2025-08-05 — — US disclosed
EP-4526298-A1 PYRAZOLE DERIVATIVES AS STING AGONISTS F. Hoffmann-La Roche AG (CH) 2025-03-26 — — EP disclosed
US-4242497-A Production of amino-silicate compounds, condensation resinous products BLOUNT DAVID H 1980-12-30 — — US disclosed
US-4191779-A P-SUBSTITUTED BENZOIC ACID STANLEY DRUG PRODUCTS, INC. (US) 1980-03-04 — — US disclosed
US-4185147-A Production of amino-silicate compounds, condensation resinous products and foam BLOUNT DAVID H 1980-01-22 — — US disclosed
US-4146509-A ORGANIC AMMONIUM COMPOUNDS USED AS POLYMERIZATION CATALYSTS BAYER AKTIENGESELLSCHAFT (DE) 1979-03-27 — — US disclosed
US-4142030-A POLYURETHANE-SILICATE BAYER AKTIENGESELLSCHAFT (DE) 1979-02-27 — — US disclosed
US-4042536-A POLYISOCYANATE, SILICIC ACID, XEROGEL BAYER AKTIENGESELLSCHAFT (DT) 1977-08-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12582641-B2 Sulfur-containing compound based on glutarimide skeleton and application thereof SUCNR1, SRD5A1, GLS ALDH1A1 697/4885TP53 309/4885TSHR 1830/4885
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors MERTK, RET, ERBB2 ALDH1A1 3864/4885TP53 816/4885TSHR 444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.